Dynamics of chemosensitivity and chromosomal instability in recurrent glioblastoma

Por Spiegl-Kreinecker, S, Pirker, C, Marosi, C, Buchroithner, J, Pichler, J, Silye, R, Fischer, J, Micksche, M, Berger, W
Publicado em 2007

Routine psychosocial distress screening in radiotherapy: implementation and evaluation of a computerised procedure

Por Dinkel, A, Berg, P, Pirker, C, Geinitz, H, Sehlen, S, Emrich, M, Marten-Mittag, B, Henrich, G, Book, K, Herschbach, P
Publicado em 2010

P02.10 Aggressiveness of meningiomas is predicted by cell immortalization in vitro and dependent on TERT promoter mutations

Por Spiegl-Kreinecker, S, Lötsch, D, Neumayer, K, Kastler, L, Gojo, J, Pirker, C, Pichler, J, Weis, S, Kumar, R, Webersinke, G, Gruber, A, Berger, W
Publicado no Neuro Oncol (2018)

Multidrug-resistant cancer cells are preferential targets of the new antineoplastic lanthanum compound KP772 (FFC24)

Por Heffeter, P., Jakupec, M.A., Körner, W., Chiba, P., Pirker, C., Dornetshuber, R., Elbling, L., Sutterlüty, H., Micksche, M., Keppler, B.K., Berger, W.
Publicado em 2007

Loss of CUL4A expression is underlying cisplatin hypersensitivity in colorectal carcinoma cells with acquired trabectedin resistance

Por Englinger, B, Mair, M, Miklos, W, Pirker, C, Mohr, T, van Schoonhoven, S, Lötsch, D, Körner, W, Ferk, F, Knasmüller, S, Heffeter, P, Keppler, B K, Grusch, M, Berger, W
Publicado no Br J Cancer (2017)

New cellular tools reveal complex epithelial–mesenchymal interactions in hepatocarcinogenesis

Por Sagmeister, S, Eisenbauer, M, Pirker, C, Mohr, T, Holzmann, K, Zwickl, H, Bichler, C, Kandioler, D, Wrba, F, Mikulits, W, Gerner, C, Shehata, M, Majdic, O, Streubel, B, Berger, W, Micksche, M, Zatloukal, K, Schulte-Hermann, R, Grasl-Kraupp, B
Publicado em 2008